what country is retatrutide available produces up to 30.3% weight loss in Phase 3 trial SOLIQUA® 100/33 (insulin glargine meets Quantity:2 Bottles (60 Day Supply)

what country is retatrutide available produces up to 30.3% weight loss in Phase 3 trial SOLIQUA® 100/33 (insulin glargine meets Quantity:2 Bottles (60 Day Supply)

SOLIQUA® 100/33 (insulin glargine & lixisenatide) injection 100 Units/mL & 33 mcg/mL | HCP

Second, patients must meet clinical eligibility requirements and obtain prior authorization from their healthcare provider

meets

Quantity:2 Bottles (60 Day Supply)

Retatrutide groups: ~ 75% reduction in WOMAC pain score Placebo group: 40.3% reduction [9] Comparison With Other Medications Semaglutide (Ozempic) 68-week trial ~15% average weight loss In overweight/obese participants without diabetes [10] Tirzepatide 72-week trial Highest dose (15 mg): ~ 21% average weight loss 2,539 participants without diabetes [11] Takeaway Retatrutide clearly sets a new bar for weight loss effectiveness — but that’s not the full story